• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins ‒ A new frontier.SARS-CoV-2 与宿主蛋白的互蛋白翻译后修饰——一个新的前沿领域。
Exp Biol Med (Maywood). 2021 Apr;246(7):749-757. doi: 10.1177/1535370220986785. Epub 2021 Jan 19.
2
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.SARS-CoV-2 进化适应宿主进入和识别病毒-宿主相互作用中受体 O-乙酰神经氨酸糖基化。
Int J Mol Sci. 2020 Jun 26;21(12):4549. doi: 10.3390/ijms21124549.
3
Protein post-translational modification in SARS-CoV-2 and host interaction.SARS-CoV-2 与宿主相互作用中的蛋白质翻译后修饰。
Front Immunol. 2023 Jan 13;13:1068449. doi: 10.3389/fimmu.2022.1068449. eCollection 2022.
4
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.SARS-CoV-2 策略性地模拟人类 ENaC 的蛋白水解激活。
Elife. 2020 May 26;9:e58603. doi: 10.7554/eLife.58603.
5
Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.蛋白质组学方法研究 SARS-CoV-2 生物学和 COVID-19 病理学。
J Proteome Res. 2021 Feb 5;20(2):1133-1152. doi: 10.1021/acs.jproteome.0c00764. Epub 2021 Jan 19.
6
A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells.一种结构保守的 SARS-CoV-2 ORF1a RNA 和 S mRNA 内的 RNA 元件,通过病毒 S 蛋白诱导的人肺细胞信号通路调节翻译。
J Virol. 2022 Jan 26;96(2):e0167821. doi: 10.1128/JVI.01678-21. Epub 2021 Nov 10.
7
Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.寻找与 COVID-19 相关的途径:通过 SARS-CoV-2-宿主相互作用组确认发病机制。
Cell Death Dis. 2021 Aug 12;12(8):788. doi: 10.1038/s41419-021-03881-8.
8
Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.基于质谱分析 SARS-CoV-2 的开放科学资源。
J Proteome Res. 2021 Mar 5;20(3):1464-1475. doi: 10.1021/acs.jproteome.0c00929. Epub 2021 Feb 19.
9
Open Modification Searching of SARS-CoV-2-Human Protein Interaction Data Reveals Novel Viral Modification Sites.开放修饰的 SARS-CoV-2-人体蛋白相互作用数据搜索揭示了新型病毒修饰位点。
Mol Cell Proteomics. 2022 Dec;21(12):100425. doi: 10.1016/j.mcpro.2022.100425. Epub 2022 Oct 12.
10
Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.蛋白质组范围数据分析揭示与 SARS-CoV-2 感染相关的组织特异性网络。
J Mol Cell Biol. 2020 Jun 11;12(12):946-957. doi: 10.1093/jmcb/mjaa033.

引用本文的文献

1
Orthogonal Translation for Site-Specific Installation of Post-translational Modifications.用于翻译后修饰的定点安装的正交翻译。
Chem Rev. 2024 Mar 13;124(5):2805-2838. doi: 10.1021/acs.chemrev.3c00850. Epub 2024 Feb 19.
2
A Path-Based Analysis of Infected Cell Line and COVID-19 Patient Transcriptome Reveals Novel Potential Targets and Drugs Against SARS-CoV-2.基于通路的感染细胞系和 COVID-19 患者转录组分析揭示了针对 SARS-CoV-2 的新型潜在靶点和药物。
Front Immunol. 2022 Jul 1;13:918817. doi: 10.3389/fimmu.2022.918817. eCollection 2022.
3
The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients.炎症性疾病中的乳酸和乳酸脱氢酶,以及 COVID-19 患者的主要危险因素。
Inflammation. 2022 Dec;45(6):2091-2123. doi: 10.1007/s10753-022-01680-7. Epub 2022 May 19.
4
Human phospho-signaling networks of SARS-CoV-2 infection are rewired by population genetic variants.人群遗传变异重塑 SARS-CoV-2 感染的人类磷酸化信号网络。
Mol Syst Biol. 2022 May;18(5):e10823. doi: 10.15252/msb.202110823.

本文引用的文献

1
First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染后抗环瓜氨酸肽抗体(ACPA)阳性类风湿性关节炎的首次发作
Lancet Rheumatol. 2021 Jan;3(1):e6-e8. doi: 10.1016/S2665-9913(20)30396-9. Epub 2020 Nov 23.
2
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.SARS-CoV-2 ORF3b 是一种有效的干扰素拮抗剂,其活性可被一种自然发生的延长变异体增强。
Cell Rep. 2020 Sep 22;32(12):108185. doi: 10.1016/j.celrep.2020.108185. Epub 2020 Sep 4.
3
Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.乙酰化 K676 TGFBIp 作为 SARS-CoV-2 肺炎严重程度的诊断性血液生物标志物。
Sci Adv. 2020 Jul 31;6(31). doi: 10.1126/sciadv.abc1564. Print 2020 Jul.
4
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.新冠病毒引发的中性粒细胞胞外诱捕网介导 COVID-19 病理学。
J Exp Med. 2020 Dec 7;217(12). doi: 10.1084/jem.20201129.
5
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States.美国11721例2019冠状病毒病(COVID-19)住院患者的特征及预后
Clin Infect Dis. 2021 May 18;72(10):e558-e565. doi: 10.1093/cid/ciaa1268.
6
Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.SARS-CoV-2 编码核衣壳蛋白磷酸化位点突变及蛋白 14-3-3 隔离的结构模型。
Biochem Biophys Res Commun. 2020 Oct 29;532(1):134-138. doi: 10.1016/j.bbrc.2020.08.024. Epub 2020 Aug 15.
7
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection.ORF8 和 ORF3b 抗体是 SARS-CoV-2 早期和晚期感染的准确血清学标志物。
Nat Immunol. 2020 Oct;21(10):1293-1301. doi: 10.1038/s41590-020-0773-7. Epub 2020 Aug 17.
8
H, C, and N backbone chemical shift assignments of the apo and the ADP-ribose bound forms of the macrodomain of SARS-CoV-2 non-structural protein 3b.严重急性呼吸综合征冠状病毒2非结构蛋白3b的巨结构域的脱辅基形式和结合ADP-核糖形式的H、C和N主链化学位移归属
Biomol NMR Assign. 2020 Oct;14(2):339-346. doi: 10.1007/s12104-020-09973-4. Epub 2020 Aug 14.
9
Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population.SARS-CoV-2 大流行中的种族和民族差异:对美国多元化大都市人口 COVID-19 观察性登记的分析。
BMJ Open. 2020 Aug 11;10(8):e039849. doi: 10.1136/bmjopen-2020-039849.
10
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.木瓜蛋白酶样蛋白酶调节新型冠状病毒2的病毒传播和固有免疫。
Nature. 2020 Nov;587(7835):657-662. doi: 10.1038/s41586-020-2601-5. Epub 2020 Jul 29.

SARS-CoV-2 与宿主蛋白的互蛋白翻译后修饰——一个新的前沿领域。

Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins ‒ A new frontier.

机构信息

Department of Internal Medicine, College of Medicine, Faculty of Health Sciences, University of Manitoba, Manitoba R3E 3P4, Canada.

Department of Physiology and Pathophysiology, College of Medicine, Faculty of Health Sciences, University of Manitoba, Manitoba R3E 3P4, Canada.

出版信息

Exp Biol Med (Maywood). 2021 Apr;246(7):749-757. doi: 10.1177/1535370220986785. Epub 2021 Jan 19.

DOI:10.1177/1535370220986785
PMID:33467896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8719024/
Abstract

Posttranslational modification of proteins, which include both the enzymatic alterations of protein side chains and main-chain peptide bond connectivity, is a fundamental regulatory process that is crucial for almost every aspects of cell biology, including the virus-host cell interaction and the SARS-CoV-2 infection. The posttranslational modification of proteins has primarily been studied in cells and tissues in an intra-proteomic context (where both substrates and enzymes are part of the same species). However, the inter-proteomic posttranslational modifications of most of the SARS-CoV-2 proteins by the host enzymes and are largely unexplored in virus pathogenesis and in the host immune response. It is now known that the structural spike (S) protein of the SARS-CoV-2 undergoes proteolytic priming by the host serine proteases for entry into the host cells, and N- and O-glycosylation by the host cell enzymes during virion packaging, which enable the virus to spread. New evidence suggests that both SARS-CoV-2 and the host proteins undergo inter-proteomic posttranslational modifications, which play roles in virus pathogenesis and infection-induced immune response by hijacking the host cell signaling. The purpose of this minireview is to bring attention of the scientific community to recent cutting-edge discoveries in this understudied area. It is likely that a better insight into the molecular mechanisms involved may open new research directions, and thereby contribute to novel therapeutic modality development against the SARS-CoV-2. Here we briefly discuss the rationale and touch upon some unanswered questions in this context, especially those that require attention from the scientific community.

摘要

蛋白质的翻译后修饰,包括蛋白质侧链和主链肽键连接的酶促改变,是一种基本的调节过程,对细胞生物学的几乎所有方面都至关重要,包括病毒-宿主细胞相互作用和 SARS-CoV-2 感染。蛋白质的翻译后修饰主要在细胞和组织中在蛋白质组内环境中进行研究(其中底物和酶都是同一物种的一部分)。然而,宿主酶对大多数 SARS-CoV-2 蛋白的蛋白质间翻译后修饰以及在病毒发病机制和宿主免疫反应中的作用在很大程度上尚未得到探索。现在已知,SARS-CoV-2 的结构刺突(S)蛋白通过宿主丝氨酸蛋白酶进行蛋白水解引发进入宿主细胞,并且在病毒包装过程中通过宿主细胞酶进行 N-和 O-糖基化,从而使病毒能够传播。新的证据表明,SARS-CoV-2 和宿主蛋白都经历蛋白质间翻译后修饰,通过劫持宿主细胞信号转导在病毒发病机制和感染诱导的免疫反应中发挥作用。本文综述的目的是引起科学界对这一研究不足领域的最新前沿发现的关注。深入了解所涉及的分子机制可能会开辟新的研究方向,并有助于开发针对 SARS-CoV-2 的新型治疗模式。在这里,我们简要讨论了这方面的基本原理,并探讨了一些未解决的问题,特别是那些需要科学界关注的问题。